Building Supply Chain Resilience During COVID-19 with Real-Time Visibility Technology
As the industry has been left scrambling to ensure continuity and minimize disruptions during the pandemic, a greater focus on visibility, transparency, and agility is becoming the new normal.
The COVID-19 pandemic has stressed the global pharmaceutical supply chain in unimaginable ways. As the industry has been left scrambling to ensure continuity and minimize disruptions, a greater focus on visibility, transparency, and agility is becoming the new normal.
Gain actionable insights into how real-time monitoring helped track COVID-19 test kits
Drawing from an actual example demonstrating how real-time monitoring has helped Ipsos MORI, a global market research firm, track location and quality conditions of tens of thousands COVID-19 test kits throughout the UK, attendees will take away a better understanding of and actionable insights into:
- How real-time visibility has helped mitigate supply chain risk during the pandemic
- How stakeholder collaboration and data sharing is key to achieving supply chain resilience
- How monitoring technology will help to further automate logistics processes
- What the post-pandemic supply chain will look like
The presenters
Kelly Beaver, Managing Director, Ipsos MORI
Ada Palmadottir, MPharm, MBA, Director of Pharmaceutical Validation and Compliance, Controlant
